Robbins LLP Is Investigating the Officers and Directors of ResMed Inc. (RMD) on Behalf of Shareholders

Nachrichtenquelle: Business Wire (engl.)
18.01.2020, 00:27  |  140   |   |   

Shareholder rights law firm Robbins LLP is investigating whether certain officers and directors of ResMed Inc. (NYSE: RMD) breached their fiduciary duties to shareholders. ResMed develops, manufactures, and markets medical equipment for the treatment of sleep disordered breathing.

ResMed Inc. (RMD) Shareholders Have Legal Options

In Resmed mit Hebel investieren [Werbung]
Ich erwarte, dass Resmed steigt...
Ich erwarte, dass Resmed fällt...

Verantwortlich für diese Werbung ist die Goldman Sachs AG. Die Wertpapierprospekte und Basisinformationsblätter zu diesen Produkten erhalten Sie über www.gs.de/de/. Disclaimer

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Resmed Aktie jetzt für 4€ handeln - auf Smartbroker.de



Diesen Artikel teilen

0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel